Skip to main content
Normal View

Medicinal Products

Dáil Éireann Debate, Wednesday - 8 May 2024

Wednesday, 8 May 2024

Questions (619)

Pádraig O'Sullivan

Question:

619. Deputy Pádraig O'Sullivan asked the Minister for Health the reimbursement status of the drug ravulizumab for paroxysmal nocturnal haemoglobinuria and atypical haemolytic uremic syndrome; when he expects this drug to be made available; and if he will make a statement on the matter. [20786/24]

View answer

Written answers

Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for decisions on the pricing and reimbursement of medicines; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.

Top
Share